NRIX Nurix Therapeutics, Inc.

Fundamentals / CIK 0001549595 / USD

Nurix Therapeutics, Inc. reported $701.9M in revenue and net income of $294.9M for the trailing twelve months ended August 31, 2026 (up 8426.3% year over year), with a 41.3% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open NRIX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$110.7M$55.35M$0-$254.4MFY 2019 Revenue: $31.11MFY 2019 Net Income: -$21.70M2019FY 2020 Revenue: $17.82MFY 2020 Net Income: -$43.24M2020FY 2021 Revenue: $29.75MFY 2021 Net Income: -$117.2M2021FY 2022 Revenue: $38.63MFY 2022 Net Income: -$180.4M2022FY 2023 Revenue: $76.99MFY 2023 Net Income: -$143.9M2023FY 2024 Revenue: $54.55MFY 2024 Net Income: -$193.6M2024FY 2025 Revenue: $83.98MFY 2025 Net Income: -$264.5M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Nov 30 Nov 30 Nov 30 Nov 30 Nov 30 Nov 30 Nov 30
Revenue $83.98M $54.55M $76.99M $38.63M $29.75M $17.82M $31.11M
Research & Development $316.9M $221.6M $189.1M $184.5M $116.4M $66.49M $45.02M
Total Operating Expenses $369.6M $267.6M $232.1M $222.5M $147.6M $82.80M $53.35M
Operating Income -$285.7M -$213.0M -$155.1M -$183.9M -$117.9M -$64.98M -$22.24M
EBITDA -$276.9M -$203.7M -$147.5M -$178.5M -$115.1M -$62.80M -$19.88M
Income Before Tax -$263.7M -$193.3M -$143.9M -$180.4M -$117.1M -$63.78M -$21.46M
Income Tax Expense $760K $270K $0 $0 $131K -$20.54M $239K
Net Income -$264.5M -$193.6M -$143.9M -$180.4M -$117.2M -$43.24M -$21.70M
Basic EPS -$3.05 -$2.88 -$2.65 -$3.71 -$2.73 -$2.76 -$6.59
Diluted EPS -$3.05 -$2.88 -$2.65 -$3.71 -$2.73 -$2.76 -$6.59
Basic Shares Outstanding 86.7M 67.1M 54.3M 48.6M 42.9M 15.7M 3.3M
Diluted Shares Outstanding 86.7M 67.1M 54.3M 48.6M 42.9M 15.7M 3.3M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-08-31 2026-05-31 2026-02-28 2025-11-30 2025-08-31 2025-05-31 2025-02-28 2024-11-30
Revenue $673.1M $9.04M $6.25M $13.58M $7.89M $44.06M $18.45M $13.28M
Research & Development $79.26M $87.65M $84.14M $83.02M $86.12M $78.10M $69.66M $67.22M
Total Operating Expenses $113.6M $103.2M $98.75M $96.67M $99.28M $92.38M $81.32M $77.94M
Operating Income $559.5M -$94.20M -$92.50M -$83.09M -$91.39M -$48.32M -$62.86M -$64.66M
EBITDA $561.6M -$91.95M -$90.30M -$80.97M -$89.36M -$46.08M -$60.51M -$62.11M
Income Before Tax $563.4M -$89.81M -- -$78.22M -$86.42M -$42.70M -$56.35M -$58.54M
Income Tax Expense $13.61M -$271K $0 $0 $0 $760K $0 $8.0K
Net Income $549.8M -$89.53M -$87.17M -$78.22M -$86.42M -$43.46M -$56.35M -$58.55M
Basic EPS $4.93 -$0.81 -$0.79 -- -$1.03 -$0.52 -$0.67 --
Diluted EPS $4.73 -$0.81 -$0.79 -- -$1.03 -$0.52 -$0.67 --
Basic Shares Outstanding 111.6M 111.1M 110.1M -- 84.2M 83.9M 83.6M --
Diluted Shares Outstanding 116.2M 111.1M 110.1M -- 84.2M 83.9M 83.6M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Nov 30 Nov 30 Nov 30 Nov 30 Nov 30 Nov 30 Nov 30
Cash & Cash Equivalents $247.0M $110.0M $54.63M $64.47M $80.51M $119.4M $34.82M
Short-Term Investments -- -- -- $244.7M $215.2M $161.8M $2.90M
Cash & Short-Term Investments $592.9M $609.6M $287.9M $309.1M $295.7M $281.1M $37.72M
Accounts Receivable, Net $0 $0 -- $0 $6.00M -- --
Total Current Assets $606.8M $619.4M $295.5M $318.4M $311.1M $298.4M $39.35M
Property, Plant & Equipment, Net $22.49M $17.76M $16.81M $17.16M $11.34M $6.67M $3.87M
Long-Term Investments -- -- -- $63.88M $137.2M $90.89M $506K
Other Non-Current Assets $7.34M $3.16M $3.82M $4.02M $2.83M $177K $147K
Total Non-Current Assets $81.32M $49.96M $60.09M $98.31M $165.7M $97.91M $4.69M
Total Assets $688.1M $669.3M $355.6M $416.8M $476.8M $396.3M $44.05M
Accounts Payable $11.21M $11.48M $6.40M $5.06M $6.65M $3.41M $1.60M
Deferred Revenue (Current) $17.58M $38.36M $48.10M $37.63M $41.21M $32.80M $9.61M
Other Current Liabilities $2.10M $2.27M $751K $1.50M $659K $700K $309K
Total Current Liabilities $86.47M $95.85M $86.96M $70.66M $66.26M $44.54M $16.14M
Deferred Revenue (Non-Current) $10.01M $26.21M $45.02M $35.97M $59.02M $60.69M $35.69M
Other Non-Current Liabilities -- -- -- -- -- $850K $1.74M
Total Non-Current Liabilities $62.92M $46.50M $68.15M $42.41M $68.21M $61.53M $37.43M
Total Liabilities $149.4M $142.3M $155.1M $113.1M $134.5M $106.1M $53.57M
Total Debt (incl. Leases) $55.73M $28.30M $30.61M $11.96M $13.04M -- --
Common Stock $102K $76K $49K $47K $45K $39K $4.0K
Retained Earnings -$1.00B -$738.8M -$545.2M -$401.3M -$220.9M -$103.7M -$60.46M
Accumulated Other Comp. Income $105K $150K -$655K -$4.32M -$608K $87K -$2.0K
Total Stockholders' Equity $538.7M $527.0M $200.5M $303.7M $342.3M $290.3M -$57.71M
Total Equity $538.7M $527.0M $200.5M $303.7M $342.3M $290.3M -$57.71M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-08-31 2026-05-31 2026-02-28 2025-11-30 2025-08-31 2025-05-31 2025-02-28 2024-11-30
Cash & Cash Equivalents $720.2M $67.69M $71.19M $247.0M $78.44M $84.26M $75.92M $110.0M
Cash & Short-Term Investments $1.10B $443.5M $540.7M $592.9M $428.8M $485.8M $549.7M $609.6M
Accounts Receivable, Net $20.00M -- -- $0 -- $19.00M -- $0
Total Current Assets $1.10B $456.5M $554.4M $606.8M $440.6M $515.3M $563.7M $619.4M
Property, Plant & Equipment, Net $19.41M $20.01M $21.70M $22.49M $20.50M $18.77M $18.45M $17.76M
Other Non-Current Assets $7.95M $7.98M $7.41M $7.34M $7.38M $6.34M $5.63M $3.16M
Total Non-Current Assets $91.61M $79.06M $81.74M $81.32M $81.87M $76.22M $51.34M $49.96M
Total Assets $1.20B $535.5M $636.1M $688.1M $522.5M $591.6M $615.0M $669.3M
Accounts Payable $32.98M $12.21M $10.29M $11.21M $8.61M $5.95M $8.40M $11.48M
Deferred Revenue (Current) $8.61M $13.32M $18.75M $17.58M $25.99M $27.42M $30.59M $38.36M
Other Current Liabilities $1.49M $1.30M $1.93M $2.10M $1.73M $1.04M $2.69M $2.27M
Total Current Liabilities $130.7M $72.02M $92.20M $86.47M $82.35M $75.61M $89.99M $95.85M
Deferred Revenue (Non-Current) $10.78M $5.97M $7.58M $10.01M $15.18M $21.64M $24.15M $26.21M
Total Non-Current Liabilities $96.25M $60.89M $63.04M $62.92M $67.87M $68.34M $44.14M $46.50M
Total Liabilities $227.0M $132.9M $155.2M $149.4M $150.2M $144.0M $134.1M $142.3M
Total Debt (incl. Leases) $65.33M $58.14M $58.66M $55.73M $56.49M $51.93M $26.62M $28.30M
Common Stock $109K $104K $103K $102K $77K $76K $76K $76K
Retained Earnings -$630.1M -$1.18B -$1.09B -$1.00B -$925.0M -$838.6M -$795.1M -$738.8M
Accumulated Other Comp. Income -$210K -$145K $56K $105K $119K -$20K $226K $150K
Total Stockholders' Equity $968.3M $402.6M $480.9M $538.7M $372.3M $447.6M $480.9M $527.0M
Total Equity $968.3M $402.6M $480.9M $538.7M $372.3M $447.6M $480.9M $527.0M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Nov 30 Nov 30 Nov 30 Nov 30 Nov 30 Nov 30 Nov 30
Net Income -$264.5M -$193.6M -$143.9M -$180.4M -$117.2M -$43.24M -$21.70M
Depreciation & Amortization $8.74M $9.32M $7.53M $5.35M $2.79M $2.18M $2.35M
Stock-Based Compensation $37.97M $33.93M $33.67M $28.13M $15.80M $4.30M $510K
Change in Receivables -- $0 $0 $6.00M -$6.00M -- --
Change in Payables -$630K $5.21M $1.61M $85K $1.59M $1.23M $302K
Operating Cash Flow -$249.5M -$172.6M -$81.36M -$159.8M -$84.36M -$80K $601K
Capital Expenditure -$14.00M -$9.27M -$8.40M -$12.24M -$5.66M -$4.55M -$1.65M
Free Cash Flow -$263.5M -$181.9M -$89.77M -$172.1M -$90.03M -$4.63M -$1.05M
Purchases of Investments -$455.7M -$708.0M -$246.3M -$239.4M -$348.5M -$275.2M -$9.35M
Sales & Maturities of Investments $617.5M $459.5M $323.0M $278.8M $238.9M $25.37M $19.50M
Investing Cash Flow $147.9M -$257.7M $68.30M $27.20M -$108.3M -$254.4M $8.50M
Common Stock Issued $0 $289.8M $0 $19.40M $150.2M $218.1M --
Financing Cash Flow $238.6M $485.7M $3.22M $117.2M $153.9M $339.0M $126K
Net Change in Cash $137.0M $55.37M -$9.85M -$15.42M -$38.73M $84.54M $9.22M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-08-31 2026-05-31 2026-02-28 2025-11-30 2025-08-31 2025-05-31 2025-02-28 2024-11-30
Net Income $549.8M -$89.53M -$87.17M -$78.22M -$86.42M -$43.46M -$56.35M -$58.55M
Depreciation & Amortization $2.14M $2.25M $2.20M $2.12M $2.03M $2.24M $2.35M $2.55M
Stock-Based Compensation $10.78M $11.39M $9.40M $9.09M $9.77M $10.38M $8.72M $8.51M
Change in Payables $20.61M $1.87M -$461K $3.02M $2.23M -$2.68M -$3.21M $7.58M
Operating Cash Flow $615.6M -$96.57M -$71.91M -$67.83M -$57.38M -$63.16M -$61.09M -$48.75M
Capital Expenditure -$1.39M -$1.94M -$1.04M -$5.13M -$2.71M -$2.67M -$3.48M -$2.10M
Free Cash Flow $614.2M -$98.51M -$72.96M -$72.96M -$60.10M -$65.84M -$64.57M -$50.86M
Purchases of Investments -$149.4M -$24.63M -$255.9M -$174.3M -$103.0M -$68.17M -$110.2M -$298.2M
Sales & Maturities of Investments $182.4M $119.6M $133.2M $179.8M $156.2M $142.3M $139.2M $159.5M
Investing Cash Flow $31.58M $93.00M -$123.8M $346K $50.48M $71.50M $25.53M -$140.8M
Common Stock Issued $0 $0 $18.00M $0 $0 $0 $0 --
Financing Cash Flow $5.16M $66K $19.98M $236.0M $1.16M $6.0K $1.47M $200.5M
Net Change in Cash $652.4M -$3.51M -$175.8M $168.5M -$5.75M $8.34M -$34.08M $10.95M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Nov 30 Nov 30 Nov 30 Nov 30 Nov 30 Nov 30 Nov 30
Operating Margin -340.2% -390.5% -201.4% -476.0% -396.3% -364.7% -71.5%
Net Profit Margin -314.9% -354.9% -187.0% -466.9% -393.9% -242.7% -69.7%
Return on Equity (ROE) -49.1% -36.7% -71.8% -59.4% -34.2% -14.9% --
Return on Assets (ROA) -38.4% -28.9% -40.5% -43.3% -24.6% -10.9% -49.3%
Current Ratio 7.02x 6.46x 3.40x 4.51x 4.70x 6.70x 2.44x
Quick Ratio 6.86x 6.36x 3.31x 4.37x 4.55x 6.31x 2.34x
Debt to Equity 0.10x 0.05x 0.15x 0.04x 0.04x -- --
Revenue Growth (YoY) +54.0% -29.1% +99.3% +29.8% +66.9% -42.7% --
Operating Cash Flow Growth (YoY) -- -- -- -- -- -113.3% --
5Y Revenue / Share Growth -14.8% -91.4% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-08-31 2026-05-31 2026-02-28 2025-11-30 2025-08-31 2025-05-31 2025-02-28 2024-11-30
Operating Margin 41.3% -982.4% -439.3% -340.2% -319.3% -260.8% -408.9% -390.5%
Net Profit Margin 42.0% -928.4% -411.4% -314.9% -292.5% -234.6% -369.4% -354.9%
Return on Equity (ROE) 30.5% -84.8% -61.4% -49.1% -65.8% -46.3% -43.3% -36.7%
Return on Assets (ROA) 24.7% -63.7% -46.4% -38.4% -46.9% -35.0% -33.9% -28.9%
Current Ratio 8.44x 6.34x 6.01x 7.02x 5.35x 6.82x 6.26x 6.46x
Quick Ratio 8.57x 6.16x 5.86x 6.86x 5.21x 6.68x 6.11x 6.36x
Debt to Equity 0.07x 0.14x 0.12x 0.10x 0.15x 0.12x 0.06x 0.05x
Revenue Growth (YoY) +8426.3% -79.5% -66.1% +2.2% -37.3% +264.3% +11.3% -12.4%
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -- -282.7%
Free Cash Flow Growth (YoY) -- -- -- -- -- -- -- -311.0%
Source: SEC EDGAR CompanyFacts (CIK 0001549595) · from February 28, 2019 Data through August 31, 2026 · synced Nov 20, 2026, 05:24 UTC · Open in terminal